An improved understanding of individual risk would account for ethnicity, advancing age, family history of prostate cancer, and genetics (eg, mutations in BRCA1, BRCA2, ATM, and the mismatch repair genes). The gene discussed is BRCA2; the disease is Familial prostate cancer.